| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 64 |
| 1 | PREDNISONE | 48 |
| 2 | LEVETIRACETAM | 45 |
| 3 | ACETAMINOPHEN | 43 |
| 4 | RITUXIMAB | 42 |
| 5 | GABAPENTIN | 40 |
| 6 | METHOTREXATE SODIUM | 40 |
| 7 | METHOTREXATE | 35 |
| 8 | ACETAMINOPHEN 500MG | 31 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HALOBETASOL PROPIONATE | 16 | 0.0117 |
| 1 | CHOLIC ACID | 2 | 0.0050 |
| 2 | FINGOLIMOD LAURYL SULFATE | 1 | 0.0046 |
| 3 | MARAVIROC | 6 | 0.0026 |
| 4 | LAROTRECTINIB | 2 | 0.0022 |
| 5 | URINARY PAIN RELIEF | 1 | 0.0021 |
| 6 | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR | 1 | 0.0021 |
| 7 | DIMENHYDRINATE | 21 | 0.0020 |
| 8 | TRIMIPRAMINE | 2 | 0.0018 |
| 9 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 116 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 55 |
| 3 | Benzodiazepine [EPC] | 44 |
| 4 | Vitamin C [EPC] | 37 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 36 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 7 | Vitamin B12 [EPC] | 31 |
| 8 | Vitamin D [EPC] | 30 |
| 9 | Proton Pump Inhibitor [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 6 | 0.0026 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 8 | 0.0008 |
| 3 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |
| 4 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 5 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 6 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 7 | Antimalarial [EPC] | 4 | 0.0004 |
| 8 | Antiprotozoal [EPC] | 4 | 0.0004 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 2 | 0.0003 |